RecruitingNot ApplicableNCT03197350

Characterization of Heart Failure With Preserved Ejection Fraction


Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Enrollment

500 participants

Start Date

Dec 4, 2014

Study Type

INTERVENTIONAL

Conditions

Summary

The goals of this research will be to define some of the mechanisms underlying the progression and complications of heart failure (HF) with preserved left ventricular ejection fraction (HFPEF) Aim 1: to evaluate the differences in cardiac structure, function and fibrosis markers through the spectrum of HF stages in order to deepen the understanding of the pathophysiology driving HF progression. Aim 2: to define the mechanisms by which HF risk factors, such as hypertension, diabetes, obesity, and renal insufficiency, interact with age to increase HF risk, and to evaluate the role of precipitating factors such as myocardial ischemia, atrial fibrillation in HFPEF. Aim 3: to determine prognostic factors in HFPEF patients, by following these patients over time. Accordingly the investigators will correlate baseline data (echocardiographic, MRI or biomarkers) with incident cardiovascular events and determine whether these measures provide incremental prognostic information beyond clinical characteristics.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating heart failure where the heart's pumping strength appears normal (called heart failure with preserved ejection fraction, or HFpEF) — a condition that is poorly understood — by comparing the heart's structure and function in affected patients versus healthy controls. **You may be eligible if...** - You have been diagnosed with heart failure with typical symptoms and have had a recent hospitalisation for heart failure, or have elevated heart failure blood markers - Your heart's pumping fraction is either reduced (below 40%) or preserved (50% or higher) depending on your heart failure type - You show signs of abnormal heart relaxation on echocardiogram - Healthy volunteers without heart failure history may also be eligible as controls **You may NOT be eligible if...** - You do not have a confirmed heart failure diagnosis with appropriate imaging findings - You have conditions that would confound the study results Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTcMR

cardiac MRI done to complete the diagnosis

BIOLOGICALbiomarker

Biomarker correlation with cMR parameters Prognostic information


Locations(1)

Cliniques universitaires Saint Luc

Brussels, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03197350


Related Trials